Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Discrepant alterations in main candidate genes among multiple primary melanomas.

Colombino M, Sini M, Lissia A, De Giorgi V, Stanganelli I, Ayala F, Massi D, Rubino C, Manca A, Paliogiannis P, Rossari S, Magi S, Mazzoni L, Botti G, Capone M, Palla M, Ascierto PA, Cossu A, Palmieri G; Italian Melanoma Intergroup (IMI).

J Transl Med. 2014 May 8;12:117. doi: 10.1186/1479-5876-12-117.

PMID:
24885594
[PubMed - in process]
Free PMC Article
2.

Inter- and intra-patient heterogeneity of response and progression to targeted therapy in metastatic melanoma.

Menzies AM, Haydu LE, Carlino MS, Azer MW, Carr PJ, Kefford RF, Long GV.

PLoS One. 2014 Jan 6;9(1):e85004. doi: 10.1371/journal.pone.0085004. eCollection 2014.

PMID:
24400126
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

In situ Protein Detection for Companion Diagnostics.

Gremel G, Grannas K, Sutton LA, Pontén F, Zieba A.

Front Oncol. 2013 Oct 31;3:271. doi: 10.3389/fonc.2013.00271. Review.

PMID:
24199171
[PubMed]
Free PMC Article
4.

Comparison of Three BRAF Mutation Tests in Formalin-Fixed Paraffin Embedded Clinical Samples.

Ahn S, Lee J, Sung JY, Kang SY, Ha SY, Jang KT, Choi YL, Kim JS, Oh YL, Kim KM.

Korean J Pathol. 2013 Aug;47(4):348-54. doi: 10.4132/KoreanJPathol.2013.47.4.348. Epub 2013 Aug 26.

PMID:
24009630
[PubMed]
Free PMC Article
5.

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma.

Colombino M, Lissia A, Capone M, De Giorgi V, Massi D, Stanganelli I, Fonsatti E, Maio M, Botti G, Caracò C, Mozzillo N, Ascierto PA, Cossu A, Palmieri G.

J Transl Med. 2013 Aug 29;11:202. doi: 10.1186/1479-5876-11-202.

PMID:
23987572
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Tumor homogeneity between primary and metastatic sites for BRAF status in metastatic melanoma determined by immunohistochemical and molecular testing.

Boursault L, Haddad V, Vergier B, Cappellen D, Verdon S, Bellocq JP, Jouary T, Merlio JP.

PLoS One. 2013 Aug 20;8(8):e70826. doi: 10.1371/journal.pone.0070826. eCollection 2013.

PMID:
23976959
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice.

Heinzerling L, Kühnapfel S, Meckbach D, Baiter M, Kaempgen E, Keikavoussi P, Schuler G, Agaimy A, Bauer J, Hartmann A, Kiesewetter F, Schneider-Stock R.

Br J Cancer. 2013 May 28;108(10):2164-71. doi: 10.1038/bjc.2013.143. Epub 2013 Apr 11.

PMID:
23579220
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

KRAS gene mutations are more common in colorectal villous adenomas and in situ carcinomas than in carcinomas.

Zauber P, Marotta S, Sabbath-Solitare M.

Int J Mol Epidemiol Genet. 2013;4(1):1-10. Epub 2013 Mar 18.

PMID:
23565319
[PubMed]
Free PMC Article
9.

Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600).

Skorokhod A, Helmbold P, Brors B, Schirmacher P, Enk A, Penzel R.

PLoS One. 2013;8(3):e59221. doi: 10.1371/journal.pone.0059221. Epub 2013 Mar 26.

PMID:
23555633
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation.

Hiatt JB, Pritchard CC, Salipante SJ, O'Roak BJ, Shendure J.

Genome Res. 2013 May;23(5):843-54. doi: 10.1101/gr.147686.112. Epub 2013 Feb 4.

PMID:
23382536
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A brief history of melanoma: from mummies to mutations.

Rebecca VW, Sondak VK, Smalley KS.

Melanoma Res. 2012 Apr;22(2):114-22. doi: 10.1097/CMR.0b013e328351fa4d. Review.

PMID:
22395415
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level.

Sakaizawa K, Goto Y, Kiniwa Y, Uchiyama A, Harada K, Shimada S, Saida T, Ferrone S, Takata M, Uhara H, Okuyama R.

Br J Cancer. 2012 Feb 28;106(5):939-46. doi: 10.1038/bjc.2012.12. Epub 2012 Jan 26.

PMID:
22281663
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Specifically targeting ERK1 or ERK2 kills melanoma cells.

Qin J, Xin H, Nickoloff BJ.

J Transl Med. 2012 Jan 25;10:15. doi: 10.1186/1479-5876-10-15.

PMID:
22277029
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Genetics and epigenetics of the skin meet deep sequence.

Cheng JB, Cho RJ.

J Invest Dermatol. 2012 Mar;132(3 Pt 2):923-32. doi: 10.1038/jid.2011.436. Epub 2012 Jan 12. Review.

PMID:
22237701
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma.

Yancovitz M, Litterman A, Yoon J, Ng E, Shapiro RL, Berman RS, Pavlick AC, Darvishian F, Christos P, Mazumdar M, Osman I, Polsky D.

PLoS One. 2012;7(1):e29336. doi: 10.1371/journal.pone.0029336. Epub 2012 Jan 3.

PMID:
22235286
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and Resistance.

Sullivan RJ, Flaherty KT.

J Skin Cancer. 2011;2011:423239. doi: 10.1155/2011/423239. Epub 2011 Nov 17.

PMID:
22175026
[PubMed]
Free PMC Article
17.

Stability of BRAF V600E mutation in metastatic melanoma: new insights for therapeutic success?

Sigalotti L, Fratta E, Parisi G, Coral S, Maio M.

Br J Cancer. 2011 Jul 12;105(2):327-8. doi: 10.1038/bjc.2011.239. Epub 2011 Jun 21. No abstract available.

PMID:
21694724
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma.

Fedorenko IV, Paraiso KH, Smalley KS.

Biochem Pharmacol. 2011 Aug 1;82(3):201-9. doi: 10.1016/j.bcp.2011.05.015. Epub 2011 May 25. Review.

PMID:
21635872
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk